Synopsis: Ten days ago I completed my regimen of 28 RT treatments. I am due for my second 6-month Eligard shot in about 4-6 weeks. I had been on Zytiga/Prednisone 5mg for about nine weeks before my MO took me off of it due to high blood pressure. In my bio I mentioned that I was recently hospitalized for three days due to a blood clot in my lung - my doc feels like it may have been precipitated by the Eligard.
1. When I see my RO in a couple of weeks I would like to have good science and rationale for the (hopefully) best ADT drug for my situation.
2. A different RO and my PCP suggested that I should be "fine" without any MO drug, based on my Prolaris Boiopsy Test Report. That report indicated that I am a good candidate for:
a. Single-modal (SM) treatment (RT or surgery): the 10-year risk of PCa metastasis with SM treatment is 3.9%.
b. Multi-modal (MM) treatment (RT with ADT): the 10-year risk of PCa metastasis with MM treatment is 2.4%. The RO said those are very good numbers.
So, when I see my MO I plan to tell him I don't want to be on Zytiga or any alternative to Zytiga due to all the research that I've seen indicating that all of them carry some sort of heart issue: heart attack, stroke, death.
Back to the main question now, I also see that many of the ADT drugs have similar potential heart-related issues. Does anyone know of an ADT drug that does not carry heart-related issues?
My, and the docs I consulted with, have this rationale: my risk for metastasis over ten years is from 2-4%. Any thoughts and/or rebuttals to this logic, of staying off any MO drugs and searching for a "heart-safe" ADT? So, having a stable thoracic aneurysm and a blood clot (treating with Eliquis) I am reluctant to add a heart-risky drug to the mix.
I have not received a current PSA or testosterone test since starting my treatments, when it was 10.0. I plan to call my RO tomorrow to request this test.
Thanks.